The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jan. 29, 2013
Filed:
Sep. 30, 2009
Andrew Stamford, Chatham Township, NJ (US);
Michael W. Miller, Scotch Plains, NJ (US);
Duane Eugene Demong, Somerset, NJ (US);
William J. Greenlee, Teaneck, NJ (US);
Joseph A. Kozlowski, Princeton, NJ (US);
Brian J. Lavey, New Providence, NJ (US);
Michael K. C. Wong, Somerset, NJ (US);
Wensheng Yu, Edison, NJ (US);
Xing Dai, Cranford, NJ (US);
De-yi Yang, Morris Plains, NJ (US);
Guowei Zhou, Somerset, NJ (US);
Andrew Stamford, Chatham Township, NJ (US);
Michael W. Miller, Scotch Plains, NJ (US);
Duane Eugene DeMong, Somerset, NJ (US);
William J. Greenlee, Teaneck, NJ (US);
Joseph A. Kozlowski, Princeton, NJ (US);
Brian J. Lavey, New Providence, NJ (US);
Michael K. C. Wong, Somerset, NJ (US);
Wensheng Yu, Edison, NJ (US);
Xing Dai, Cranford, NJ (US);
De-Yi Yang, Morris Plains, NJ (US);
Guowei Zhou, Somerset, NJ (US);
Merck Sharp & Dohme Corp., Rahway, NJ (US);
Abstract
The present invention relates to compounds of the general formula: (I) wherein ring A, ring B, R, R, Z, L, and Lare selected independently of each other and are as defined herein, to compositions comprising the compounds, and to methods of using the compounds as glucagon receptor antagonists and for the treatment or prevention of type 2 diabetes and conditions related thereto.